Cargando…
Purinergic signalling in bone
Purinergic signaling in bone was first proposed in the early 1990s with the observation that extracellular ATP could modulate events crucial to the normal functioning of bone cells. Since then the expression of nearly all the P2Y and P2X receptors by osteoblasts and osteoclasts has been reported, me...
Autores principales: | Rumney, Robin M. H., Wang, Ning, Agrawal, Ankita, Gartland, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446723/ https://www.ncbi.nlm.nih.gov/pubmed/23049524 http://dx.doi.org/10.3389/fendo.2012.00116 |
Ejemplares similares
-
Absence of P2Y(2) Receptor Does Not Prevent Bone Destruction in a Murine Model of Muscle Paralysis-Induced Bone Loss
por: Agrawal, Ankita, et al.
Publicado: (2022) -
Purinergic Signaling in Spermatogenesis
por: Mundt, Nadine, et al.
Publicado: (2022) -
Purinergic Signaling in Liver Pathophysiology
por: Jain, Shanu, et al.
Publicado: (2021) -
Purinergic signaling in the male reproductive tract
por: Belardin, Larissa Berloffa, et al.
Publicado: (2022) -
Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells
por: Martin-Aragon Baudel, Miguel, et al.
Publicado: (2020)